FrieslandCampina registers Phase 3 trial of infant formula with bio-active ingredients
The study was first posted on ClinicalTrials.gov on October 9, 2026, and plans to enroll 387 participants with a start date of January 2027. It aims to compare growth, immune parameters, and gut health between infants receiving the investigational formula and those receiving a control formula.
Primary source
ClinicalTrials.gov registry record, October 9, 2026
A Clinical Trial on the Effect of Infant Formula Consumption on Growth, Immune Parameters, and Gut Health in Healthy Term Infants.
Read the source: A Clinical Trial on the Effect of Infant Formula Consumption on Growth, Immune Parameters, and Gut Health in Healthy Term Infants. clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation